Proqr Therapeutics N.v. · NASDAQ:PRQR

Filius Bart bought 150,000 Proqr Therapeutics N.v. shares (Form 4)

Traded Jul 17, 2026 · Filed Jul 21, 2026

On Jul 17, 2026, Filius Bart (Director) bought 150,000 Proqr Therapeutics N.v. shares at US$1.72 for US$258K, leaving 300,000 shares. Filed Jul 21, 2026 (Form 4).

Bought
150,000 shares
Price
US$1.72
Value
US$258K
Holding after
300,000 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 17, 2026Ordinary SharesBuy150,000US$1.72300,000Direct

Source

View original at SEC

Related